Oct 11, 2024, 16:21
Dionysis Papadatos-Pastos: First line treatment for EGFR driven NSCLC in the context of MARIPOSA and FLAURA2
Dionysis Papadatos-Pastos shared a post on X:
”My recent presentation in vumedi…discussing 1L treatment for EGFR driven NSCLC in the context of MARIPOSA and FLAURA2.”
Read further.
Source: Dionysis Papadatos-Pastos/X
Dionysis Papadatos-Pastos is a Consultant Medical Oncologist specializing in the treatment of lung cancer, mesothelioma, and thymoma. He practices at The London Clinic, Leaders in Oncology Care, Cromwell Hospital, University College London Hospitals NHS Foundation Trust, and Princess Alexandra Hospital NHS Trust.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 08:51
Dec 21, 2024, 08:48
Dec 21, 2024, 08:42
Dec 21, 2024, 08:37
Dec 21, 2024, 08:29
Dec 21, 2024, 08:12
Dec 21, 2024, 07:45
Dec 21, 2024, 05:54